The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2020

Filed:

Oct. 15, 2018
Applicant:

University of Rochester, Rochester, NY (US);

Inventors:

John L. Daiss, Rochester, NY (US);

Edward Schwarz, Rochester, NY (US);

John J. Varrone, Rochester, NY (US);

James Brodell, Rochester, NY (US);

Sheila Bello-Irizarry, Rochester, NY (US);

Assignee:

University of Rochester, Rochester, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/40 (2006.01); D21H 27/30 (2006.01); D21H 27/38 (2006.01); D21H 11/02 (2006.01); D21H 11/08 (2006.01); B32B 29/00 (2006.01); C07K 16/12 (2006.01); A61K 39/40 (2006.01); A61K 45/06 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A61K 39/40 (2013.01); A61K 45/06 (2013.01); B32B 29/005 (2013.01); C07K 16/1271 (2013.01); D21H 11/02 (2013.01); D21H 11/08 (2013.01); D21H 27/30 (2013.01); D21H 27/38 (2013.01); G01N 33/56938 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); B32B 2250/26 (2013.01); B32B 2262/0261 (2013.01); B32B 2262/062 (2013.01); B32B 2262/067 (2013.01); B32B 2307/54 (2013.01); B32B 2307/72 (2013.01); B32B 2439/00 (2013.01); B32B 2439/70 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01);
Abstract

Disclosed herein are monoclonal antibodies or binding portion thereof that bind specifically to aspp. autolysin N-acetylmuramoyl-L-alanine amidase catalytic domain and/or cell wall binding domain, as well as pharmaceutical compositions containing the same. Cell lines expressing the monoclonal antibodies, including hybridomas, are also disclosed. Methods of using the monoclonal antibodies for installation of orthopedic implants, grafts or medical devices, treating or preventing ainfection, and treating osteomyelitis are described, as are diagnostic methods for the detection ofin a sample.


Find Patent Forward Citations

Loading…